UBS Group’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76M Sell
191,630
-8,000
-4% -$3.62M 0.01% 1258
2025
Q4
$93.8M Buy
199,630
+86,100
+76% +$38.2M 0.02% 1068
2025
Q3
$56M Buy
+113,530
New +$64.2M 0.01% 1514
2025
Q1
Sell
-15,600
Closed -$7.57M 10688
2024
Q4
$7.57M Buy
15,600
+4,000
+34% +$2.09M ﹤0.01% 3367
2024
Q3
$5.87M Sell
11,600
-8,000
-41% -$4.29M ﹤0.01% 2912
2024
Q2
$11.7M Buy
19,600
+18,700
+2,078% +$10.6M ﹤0.01% 2096
2024
Q1
$514K Buy
+900
New +$495K ﹤0.01% 5189

Other funds holding SNPS

UBS Group's SNPS Position: Q1 2026 in Review

UBS Group increased its Synopsys (SNPS) stake by 177% in Q1 2026, buying an estimated $556M and bringing the position to 1,925,114 shares worth $763M. The position accounts for 0.11% of the portfolio, ranked #171.

UBS Group first reported a position in SNPS in Q4 2014 and has held it in 46 quarters since. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • UBS Group held 1,925,114 shares of Synopsys worth $763M as of Q1 2026.
  • UBS Group bought 1,229,995 Synopsys shares in Q1 2026, an estimated $556M.
  • Synopsys made up 0.11% of UBS Group's portfolio in Q1 2026, its #171 holding.
  • UBS Group first reported a position in Synopsys in Q4 2014 and has held it in 46 quarters since.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.